Article
Portability is no longer a device feature—it is a system-level lever shaping care delivery, workforce design, and financial performance.
Health systems are increasingly defined by their ability to deliver care beyond hospital walls. But decisions about where care happens are often made passively, driven by departmental habits rather than enterprise strategy.
Portable medical technologies expose this disconnect. When evaluated narrowly through a supply or product lens, their broader impact on throughput, workforce models, and capital allocation are often missed.
For executive leaders, it’s crucial that portability is not treated as a feature but as a strategic lever within a decentralized care model.
Healthcare delivery continues to evolve under the weight of chronic disease, workforce constraints, and new care models. More than half of U.S. adults live with multiple chronic conditions, driving utilization and cost. Mobility plays a critical role in managing these conditions, making portable diagnostics, monitoring, and therapy increasingly relevant across sites of care.
In acute care, reducing length of stay remains a persistent priority. Portable devices enable faster assessment, earlier access to clinical data, and more timely decision-making—while supporting patient mobility and reducing reliance on stationary equipment. These capabilities extend across point-of-care diagnostics, cardiovascular and pulmonary care, wound management, and venous and edema therapies.
The implications go beyond clinical care. Portability influences throughput, capacity management, and financial performance, elevating it from a clinical consideration to an enterprise priority.
At the same time, hospitals are navigating persistent challenges including emergency department crowding, staffing shortages, and the expansion of care into outpatient and home settings. Portable, bedside-ready technologies support efficient workflows by bringing monitoring and diagnostics directly to the patient, reducing delays and reliance on shared resources.
As these pressures intensify, portability is becoming foundational to modern care delivery. Here are six strategies for leadership as they consider integrating portable technologies:
1. Assess enterprise readiness for scale: Readiness extends beyond the technology itself and includes governance, clinical workflows, and a culture that supports change. This includes the ability to standardize, digital interoperability, availability of clinical and sourcing expertise, and leadership alignment to support adoption at scale.
As adoption expands across the care continuum, aligning these technologies to a cohesive care model becomes increasingly important. Equally important is fostering a continuous learning environment that enables teams to adapt, optimize device utilization, and sustain long-term value from portable, integrated care solutions.
2. Assess connectivity, interoperability, and enterprise data strategy: An increasing number of portable monitoring devices are capable of automatically integrating data into the electronic health record, supporting improved workflow efficiency and documentation accuracy. Real-time data capture and visibility into patient status can enable more timely clinical decision-making and earlier intervention.
Additionally, these devices represent a growing source of actionable clinical data that can inform analytics, performance improvement, and future automation efforts.
To maximize these benefits, organizations should assess both the interoperability capabilities and potential limitations of portable devices, with particular attention to data reliability, system compatibility and the opportunity to reduce clinical documentation burden.
3. Evaluate cost, value, and investment priorities: Evaluating the total cost of ownership in relation to desired clinical outcomes is a core function of value analysis teams and requires close collaboration among sourcing, clinical, and financial stakeholders—especially during the RFP process.
For executives, these decisions increasingly require a clear understanding of how portable technologies contribute to optimizing performance and long-term value.
Reimbursement considerations, including payer coverage for portable devices, may further influence adoption decisions. Additionally, when these devices are required beyond the inpatient setting, organizations must plan for patient and caregiver education, access, and ongoing support.
4. Engage clinicians and consider workforce implications: These technologies may influence where and by whom care is delivered, with implications for staffing models, training, and the distribution of work across care teams.
Early and transparent engagement with clinicians, particularly when transitioning from stationery or traditional devices, supports shared decision-making and builds trust in the change process. Inviting clinicians to share real-world experiences and workflow insights enables leaders to better anticipate adoption barriers and clinical needs.
5. Ensure quality and safety: Advancing quality of care, reducing harm, and enhancing patient safety remain core priorities for health systems adopting new technologies. Portable medical devices can support these goals by enabling patient mobility and, in some cases, reducing risks associated with prolonged immobility or reliance on shared stationary equipment, such as hospital-acquired infections. During the sourcing and evaluation process, systematically reviewing clinical evidence and real-world outcomes allows organizations to balance potential benefits with identified risks.
6. Consider cybersecurity and data security: Recent high-profile cybersecurity incidents across the healthcare ecosystem have reinforced the importance of proactively addressing these risks as part of technology adoption.
Successful integration requires enhanced safeguards, including secure device configurations, asset tracking, routine software updates, and targeted cybersecurity education for end users. Collaboration across information technology, legal, compliance, clinical, and sourcing stakeholders is essential to assess potential security impacts and ensure devices meet organizational and regulatory requirements. Incorporating cybersecurity considerations early in clinical and sourcing decision-making helps protect patient data while supporting safe and scalable device adoption.
As discussions around digitally enabled devices accelerate, portability is emerging as a defining factor in care delivery design. The central question is no longer whether to adopt these technologies—but how to integrate them strategically. Organizations that treat portability as a series of product decisions will capture incremental value. Those that embed it within a broader care delivery are better positioned to see real operational and financial impact.
An integrated, cross-functional approach, grounded in clinical engagement and data-driven evaluation, provides a strong foundation for sourcing decisions and the responsible integration of portable device technologies.
Vizient Senior Clinical Manager, Spend Management
In her role at Vizient, Ashley Neal serves as a senior clinical manager on the medical/surgical spend management team, providing clinical subject matter expertise and integrating evidence-based research and insights into the contracting process. She also promotes improvements in quality and patient safety, healthcare worker safety, and supply chain outcomes. Neal has 18 years of healthcare and nursing...
